Nanyue Biotech

Guangdong Nanyue Biopharmaceutical is a specialized biopharmaceutical company focused on the development and production of plasma-derived therapies. Headquartered in Foshan, China, the company operates a large-scale, GMP-certified manufacturing facility dedicated to processing human plasma into life-saving medicines. Its commercial portfolio includes essential products such as human albumin, intravenous immunoglobulin (IVIG), and specific immunoglobulins for hepatitis B and tetanus. As a key player in the Chinese blood products market, Nanyue Biopharma emphasizes quality control and technological innovation in its fractionation processes. The company is a subsidiary of the state-owned Guangdong Nanyue Group, providing it with robust institutional support. Its mission centers on addressing the clinical demand for blood-derived products in critical care and immunology.